Last reviewed: June 9, 2026 Last updated: June 9, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Alpha-lipoic acid: physiologic mechanisms and indications for the treatment of metabolic syndrome
Is intravenous glutathione more effective than oral forms
Journal of Clinical Endocrinology and Metabolism 2020
The platform has genuine strengths, some serious structural weaknesses, and a reputation that has shifted meaningfully in recent months based on real user feedback
Tominaga H, Katoh H, Odagiri K, Takeuchi Y, Kawashima H, Saotome M, et al